Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Dec 22, 2022 8:32pm
200 Views
Post# 35188447

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:7500000

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:7500000Someday I'm going to write a book on the likes of your psyche and the irrational mindset of most investors.  You and several others along with hundreds of thousands on other boards wishing for the demise of a company they made a choice to invest in, blaming others (who should always be a champion for a stock they're invested in) for your investment choice when there were so many other options (no one forced you), and then self-sabotaging their own investments by ranting like raging lunatics about everything they hate about their investment.

Or is it more nefarious?  Short-sellers, disgruntled former employees, competition from competitors trying to paint THTX in a bad light?  That would make much more sense.  

I'll be the first to criticize the company's communication strategy, but that's to highlight the opportunities for improvement, not to tear the company down and make other investors think THTX isn't worth investing in.  You guys are weird.

Momo25 wrote: You are very correct. In few weeks, you will see again the SPECEO alike chanting again Aleluia Th is back with the start of a very promising new Phase 1-b and/or an extarordinary Nash program. 


<< Previous
Bullboard Posts
Next >>